Trade Viatris Inc. - VTRS CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.09 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023346% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001124% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 11.28 |
| Open | 11.32 |
| 1-Year Change | -0.53% |
| Day's Range | 11.24 - 11.35 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jan 21, 2025 | 11.27 | 0.01 | 0.09% | 11.26 | 11.38 | 11.23 |
| Jan 17, 2025 | 11.25 | -0.06 | -0.53% | 11.31 | 11.43 | 11.20 |
| Jan 16, 2025 | 11.29 | 0.05 | 0.44% | 11.24 | 11.34 | 11.09 |
| Jan 15, 2025 | 11.33 | -0.47 | -3.98% | 11.80 | 11.86 | 11.12 |
| Jan 14, 2025 | 11.68 | -0.15 | -1.27% | 11.83 | 11.97 | 11.61 |
| Jan 13, 2025 | 11.75 | 0.15 | 1.29% | 11.60 | 11.75 | 11.51 |
| Jan 10, 2025 | 11.62 | -0.13 | -1.11% | 11.75 | 11.81 | 11.52 |
| Jan 8, 2025 | 11.92 | 0.03 | 0.25% | 11.89 | 12.01 | 11.71 |
| Jan 7, 2025 | 11.96 | 0.08 | 0.67% | 11.88 | 12.13 | 11.88 |
| Jan 6, 2025 | 11.90 | -0.27 | -2.22% | 12.17 | 12.29 | 11.85 |
| Jan 3, 2025 | 12.24 | -0.17 | -1.37% | 12.41 | 12.42 | 12.20 |
| Jan 2, 2025 | 12.38 | -0.04 | -0.32% | 12.42 | 12.55 | 12.28 |
| Dec 31, 2024 | 12.41 | 0.08 | 0.65% | 12.33 | 12.55 | 12.33 |
| Dec 30, 2024 | 12.34 | -0.03 | -0.24% | 12.37 | 12.43 | 12.24 |
| Dec 27, 2024 | 12.45 | 0.00 | 0.00% | 12.45 | 12.63 | 12.35 |
| Dec 26, 2024 | 12.51 | 0.21 | 1.71% | 12.30 | 12.57 | 12.30 |
| Dec 24, 2024 | 12.35 | 0.12 | 0.98% | 12.23 | 12.36 | 12.09 |
| Dec 23, 2024 | 12.45 | 0.02 | 0.16% | 12.43 | 12.46 | 12.15 |
| Dec 20, 2024 | 12.48 | 0.32 | 2.63% | 12.16 | 12.52 | 12.10 |
| Dec 19, 2024 | 12.08 | -0.09 | -0.74% | 12.17 | 12.33 | 12.04 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Viatris Inc. Company profile
Viatris (VTRS) is a global healthcare company. It was formed in 2020 through the merger of Pfizer’s (PFE) off-patent branded and generic medicines division Upjohn and pharmaceutical firm Mylan.
The merger of Mylan and Upjohn was announced in July 2019 and received final regulatory clearance in October 2020. Pfizer shareholders own 57% of Viatris and Mylan shareholders own 43%, according to the merger announcement. Viatris started trading on the Nasdaq Stock Exchange under the ticker VTRS in November 2020.
Viatris is headquartered in Canonsburg, Pittsburgh, US. The company is operational in over 165 countries and has global centres in Shanghai, China and Hyderabad, India.
Viatris operates about 40 manufacturing sites which produce oral solid doses, injectables, complex dosage forms and active pharmaceutical ingredients. The firm also produces numerous complex generics, biosimilars and global key brands.
Viatris offers treatment options across more than 10 major therapeutic areas covering a wide variety of non-communicable and infectious diseases. According to the company’s website, 50% of its total active pharmaceutical ingredient (API) capacity is devoted to antiretroviral (ARV), which is used against HIV infection.
Some of the well-known and key brands under Viatris are anxiety treatment drug Xanax, antidepressant Zoloft, anti-inflammatory drug Celebrex and erectile dysfunction therapy Viagra, among others. Viatris also offers global biosimilars franchises focused on the areas of oncology, immunology, endocrinology, ophthalmology and dermatology.
| Industry: | Pharmaceuticals (NEC) |
1000 Mylan Boulevard
CANONSBURG
PENNSYLVANIA 15317
US
News
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
15:24, 21 January 2025
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025
Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
12:40, 31 December 2024
Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024
Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024
Projected UK interest rates in 5 years
Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?
11:20, 12 December 2024
Dogecoin (DOGE) price prediction 2025-2030: Could Dogecoin reach $1? - Third party price target
We look at the meme coin’s price performance and the latest DOGE price predictions
08:37, 12 December 2024People also watch
Still looking for a broker you can trust?
Join the 680,000+ traders worldwide that chose to trade with Capital.com